Something strange is happening with malnutrition. It’s by far the fastest-growing cause of death in America, soaring sixfold ...

I’ve been the doctor responding to medical emergencies on a flight, and the medical kits I used contained minimal supplies.

During 3 decades in my field, I’ve seen scope-of-practice battles between optometrists and ophthalmologists impede the ...

With durable responses, encouraging survival outcomes, and evidence that some patients may become eligible for ...

When Louise and I lived in Germany in the 1980s, we visited Neuschwanstein Castle, the fantasy palace perched on a Bavarian ...

Favorable safety, tolerability, pharmacokinetic and pharmacodynamic profiles validate and significantly de-risk the ...

Editorial Note: We earn a commission from partner links on Forbes Advisor. Commissions do not affect our editors' opinions or evaluations. Disclaimer: Calculator results and default inputs are ...

Published NAD+ research examines cellular aging pathways and mitochondrial function as prescription peptide injection access expands through telehealth — here is what the RenuviaRX platform model, ...

Wolfe upgraded Merck to Outperform from Peer Perform and set a $135 price target, saying the drugmaker is approaching a new ...

Investing.com -- TransCode Therapeutics (NASDAQ:RNAZ) stock surged 18% on Tuesday after the company published preclinical data showing its lead candidate TTX-MC138 demonstrated therapeutic potential ...

Preliminary Q4 2025 PEMGARDA® (pemivibart) net product revenue of $17.2 million, representing 25% growth year-over-year and 31% growth ...